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Abstract This study was carried out in Atatˇrk Chest Diseases and Surgery Center. It’s aimto determine and com-
pare sputum adenosine deaminase (ADA) activity in pulmonary tuberculosis (tb), lung cancer and chronic obstructive
pulmonary disease (COPD) patients in order to assess its diagnostic value. Patients and method: Eighty-four patients
(25 tb, 30 lung cancer and 29 COPD) were included in the study. ADA activity in sputum and serum was measured.
Sputum ADA activities of tb patients were significantly higher than the other two groups (Po0.05). Sputum/serum
ADA ratios were similar in all groups. Sputum ADA activities between150 and 200 U/L were the measurements with
the best test performance according to the ROC curve. Sensitivity, specificity, positive predictive value, and negative
predictive value were 44.0, 86.4, 57.8, 78.4% for150U/L and 32.0,96.6, 80.0, 77.0% for 200U/L, respectively. Area under
the curve was 0.663. Because of low sensitivity, routine determination of ADA activity in sputum for the diagnosis of
pulmonary tb is not recommended.However, it can be helpful in the diagnosis of smear-negative caseswho are strongly
suspected oftb.r2002 Publishedby Elsevier Science Ltd
doi:10.1053/rmed.2002.1321, available online at http://www.idealibrary.comon
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Successful treatment of tb largely depends on early diag-
nosis and the most important diagnostic method is to
detect the bacilli bacteriologically. However, as this is
not always possible, new methods are being developed
and used (1).
Adenosine deaminase (ADA) is an enzyme catalyzing
the hydrolytic and irreversible deamination of adenosine
to inosine and deoxyadenosine to deoxyinosine. ADA is
used for the diagnosis of pleural tb and there are studies
showing high levels of ADA in sera and bronchoalveolar
lavage (BAL) £uids of tb patients (2^9). However only a
few studies have focused on ADA activity in materials
obtained by non-invasive methods, such as sputum (10).
We, therefore,measured and compared sputum and ser-
um ADA activities in pulmonary tuberculosis (tb), lung
cancer and chronic obstructive pulmonary diseaseReceived 20 July 2001, accepted in revised form 9 January 2002.
This articlewas presented as a thematic poster in the10th European
Respiratory Society Annual Congress, Florence, 2000.
Correspondence should be addressed to:Dr G lˇnur !nde "c oluk,
Hatir sok.No:17, 06700 Gaziosmanpasa, Ankara,Turkey.Fax: +90 312
355 2135; E-mail:ucoluk@ceng.metu.edu.tr(COPD) patients in order to assess this test’s diagnostic
value.
MATERIALSANDMETHODS
Eighty-four patients (25 with pulmonary tb, 30 with lung
cancer and 29withCOPD)whowere followedup inAta-
tˇ rk Chest Diseases and Surgery Center were included
in the study.Twenty-two of the tb patients were smear-
and culture-positive and the remaining three were
smear-negative, and culture-positive.
Earlymorning sputum and 5 cc venousbloodwere ob-
tained from all patients.Blood samples were centrifuged
at 3500 rpm for10min to separate the sera.
Sputum samples were homogenized with 70 milli-mol
phosphate bu¡er (pH: 6.0) containing 0.5mol NaCl (1ml
sputum + 5ml bu¡er). They were centrifuged at
5000 rpm for 30min and ADA activity of the superna-
tant was measured by Guisti method. Results were cor-
rected by multiplying with the dilution coe⁄cient. All
measurementswere done on the same day sampleswere
obtained.
A serumADA activity between14 and 20U/lwas con-
sidered normal. Enzyme activities in three groups were
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di¡erence was found, pair-wise post hoc comparisons
were carried out usingTukey’s honestly signi¢cant test.
When the study population was divided into tb and
non-tb groups, t-testwasused.Correlationbetween ser-
um and sputum values was assessed by Pearson correla-
tion test. Speci¢city, sensitivity, positive predictive value,
negative predictive value and area under the curvewere
calculatedusing ROC curve.
RESULTS
Number of patients, mean ages, sexdistribution, sputum
ADA, serum ADA measurements and sputum/serum
ADA (ADA ratio) of the groups are shown inTable1.
Mean age of tb groupwas signi¢cantly lower than the
other twogroups (Po0.001).Otherdemographic charac-
teristics were similar in all groups.
Sputum ADA activities in the tb group were signi¢-
cantly higher than the other two groups (Po0.01for lung
cancer group,Po0.05 forCOPD).Therewas a signi¢cant
di¡erence in serum ADA activities between tb and can-
cer groups (Po0.05). ADA activities in sera were similar
in tb- and cancer-COPD comparisons (P40.05). Sputum/
serum ADA ratios were similar in all groups (P40.05).
ADA activity in serum and sputum in tb groupwas sig-
ni¢cantly higher than thenon-tb groups (Po0.05).Ratios
were similar.
Whenwe tried to set a cut-o¡ point for sputum ADA
activities of tb and non-tb groups, values between 150
and 200U/l were the ones with the best speci¢city. Sen-
sitivity, speci¢city, positive predictive value (PPV), and
negative predictive value (NPV) were 44.0, 86.4, 58.8,TABLE 2. Sensitivity, speci¢city,PPV,NPVand AUCvalues for A
Cut-o¡
(IU/l)
Sensitivity
(%)
Speci¢city
(%)
150 44 86.4
200 32 96.6
TABLE 1. Numberofpatients, sexdistribution,meanages, sputu
the patients
Groups n Male Female Age (mean7
Tb 25 23 2 38.8715.
Neoplasm 30 30 F 60.1710
COPD 29 22 7 61.2710.
Non-tb (COPD+Neoplasm) 59 52 7 60.671078.4% for 150U/l and, 32.0, 96.6, 80.0, 77.0% for 200U/l,
respectively. AUC for ADA activity in sputumwas calcu-
lated as 0.66 (Table 2).This value was signi¢cantly higher
than 0.5 (Po0.05).
There was no correlation between ADA activities in
sputum and serum of tb group (P: 0.681).However, there
was a signi¢cant correlation in non-tb group (P: 0.0047).
Distribution of ADA activities in sputum is shown in
Fig.1.
DISCUSSION
ADA is an enzyme that takes part in lymphoid cell di¡er-
entiation andmonocyte, macrophagematuration. Its ac-
tivity is high in lymphocytes and monocytes and it has
two isoenzymes designated A1and A2 (11).High ADA ac-
tivity in pleural £uid is valuable for the diagnosis of tb
pleurisy in countries with high tb prevalence (2).
High ADA activity in pleural e¡usions of patients with
other diseases as lymphoproliferative disorders,
bronchogenic cancer, pulmonary embolism, systemic lu-
pus erythematosus, rheumatoid arthritis, empyema, li-
ver diseases, mesothelioma, parapneumonic and
idiopathic £uid lower the speci¢city. Additionally, ADA
levels can be initially low in tb e¡usions and may rise in
repeatedmeasurements (5).
ADA activity in BAL £uid of patients with pulmonary
tbwashigher thanpatientswithmalignancies (8,9).How-
ever, serum ADA activity was similar in two groups (8).
In the diagnosis of tb, sputum smear and culture are rou-
tinely used and are reliable. Sophisticated methods like
BACTEC, polymerase chain reaction (PCR), nucleic acidDA activity in sputumoftb andnon-tb groups
PPV
(%)
PPV
(%)
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Fig 1. Sputum ADAactivities ofthe studygroups.
634 RESPIRATORYMEDICINEprobe and biochemical analysis such as tuberculostearic
acidmay increase diagnostic yield (12).
ADA levels have so far beenmeasured inmaterials ob-
tained by invasive methods such as BAL and thoracent-
esis and only a few studies have depended on non-
invasivemethods.
Dimakou and colleagues found signi¢cantly higher
ADA activity in sputums of 22 tb patients than 13 lung
cancer patients. Sensitivity was 60%, speci¢city was
92% with a cut-o¡ level of15U/l (10).
Sputum ADA activity of the tb groupwas signi¢cantly
higher than other groups in our study.We obtained the
best speci¢city values with cut-o¡ points between 150
and 200U/l. As in Dimakou and colleagues’ study, we
found low sensitivity values with moderate speci¢cities.
We have included COPD patients as well as lung cancer
patients as controls.However, whenwe excludedCOPD
group, similar resultswere obtained (with a cut-o¡ point
of150U/l, sensitivity was 44%, speci¢city 90%, and AUC
0.678).
Itmustbe noted that two of the three smear-negative
patients had sputum ADA levels of150U/l.ADA activity in sputum of our tb patients was strik-
ingly higher than those observedbyDimakou and collea-
gues.This can be explained by the standard dilution and
multiplication of the result by the dilution coe⁄cient (6).
Because of low sensitivity, theseresults are insu⁄cient
to recommend ADA activity in sputum as a diagnostic
method for pulmonary tb.But, since sputumis amaterial
that can be obtained by non-invasivemethods, in smear-
negative patients who are strongly suspected to have
pulmonary tb, the determination of ADA activity in spu-
tum can be helpful. Further studies on new methods to
diagnose tb in smear-negative patients are needed.
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